---
title: Validate Turkish involuntary movements scale
nct_id: NCT07023224
status: RECRUITING
sponsor: Izmir Bakircay University
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07023224"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07023224"
last_fetched: "2026-05-10T14:03:04.316Z"
source: "Parkinson's Pathways (curated)"
---
# Validate Turkish involuntary movements scale

**Goal (in five words):** Validate Turkish involuntary movements scale

**Official Title:** Adaptation Of The Parkinson's Disease Dyskinesia Questionnaire Into Turkish And Its Validity And Reliability In Parkinson's Patient

**Trial ID:** [NCT07023224](https://clinicaltrials.gov/study/NCT07023224)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Izmir Bakircay University
- **Target Enrollment:** 130 participants
- **Start Date:** 2024-11-14
- **Completion Date:** 2025-11-30
- **Conditions:** Idiopathic Parkinson Disease, Dyskinesias, Quality of Life
- **Interventions:** Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
- **Intervention Types:** OTHER

## Summary For Families

They want to adapt the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and make sure the translation accurately measures dyskinesias and how those involuntary movements affect quality of life. The team will have people with Parkinson's complete the Turkish PDYS-26 and test its validity and reliability, checking whether responses consistently reflect the frequency, severity, and daily-life impact of dyskinesia so clinicians and researchers can trust the tool. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who have at least mild dyskinesia on the UPDRS, can give consent, and score 24 or higher on the Mini Mental State Exam are eligible, while those with atypical parkinsonism or major health problems that would affect assessments are excluded.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Being diagnosed with idiopathic Parkinson's disease
* H\&Y stage 1-3
* UPDRS dyskinesia item score ≥1
* Accepting to participate in the study

Exclusion Criteria:

* Diagnosis of atypical-secondary parkinsonism
* Severe musculoskeletal, neurological and/or cardiopulmonary problems that may affect the results of the assessment
* Mini Mental State Examination score \< 24
```

## Locations (2)

- Bakirçay University Çiğli Regional Education Hospital, Izmir, İ̇zmi̇r, Turkey (Türkiye) _(38.4127, 27.1384)_
- Izmir Bakırçay Univercity, Izmir, Turkey (Türkiye) _(38.4127, 27.1384)_

## Central Contacts

- Irem Tepe Bark, PT — (CONTACT) — +905537491143 — fztiremtepe@gmail.com
- Gulbin Ergin, PT, PhD — (CONTACT) — +90 232 493 00 00 — gulbin.ergin@bakircay.edu.tr

---

*Canonical: https://parkinsonspathways.com/trial/NCT07023224*  
*HTML version: https://parkinsonspathways.com/trial/NCT07023224*  
*Source data: https://clinicaltrials.gov/study/NCT07023224*